Oral nanoparticulate curcumin combating arsenic-induced oxidative damage in kidney and brain of rats

Toxicology and Industrial Health

Volumn 32, Issue 3, 2016, Pages 410-421

  Sankar, Palanisamy ^a   Telang, Avinash Gopal ^a   Kalaivanan, Ramya ^a   Karunakaran, Vijayakaran ^a   Suresh, Subramaniyam ^a   Kesavan, Manickam ^a  

^a VETERINARY COLLEGE   (India)

Author keywords

Arsenic; brain; curcumin; kidney; nanoencapsulation; oxidative stress

Indexed keywords

ARSENITE SODIUM; CATALASE; CREATININE; CURCUMIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; SUPEROXIDE DISMUTASE; UREA; ANTIOXIDANT; ARSENIC; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; BRAIN INJURY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EMULSION; HISTOPATHOLOGY; KIDNEY; KIDNEY INJURY; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE DAMAGE; OXIDATIVE STRESS; PARTICLE SIZE; RAT; TISSUE INJURY; UREA NITROGEN BLOOD LEVEL; ANIMAL; BRAIN CHEMISTRY; BRAIN DISEASE; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; KIDNEY DISEASE; MALE; ORAL DRUG ADMINISTRATION; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; ARSENIC; BRAIN CHEMISTRY; BRAIN DISEASES; CURCUMIN; KIDNEY; KIDNEY DISEASES; MALE; NANOPARTICLES; OXIDATIVE STRESS; PARTICLE SIZE; RATS; RATS, WISTAR;

EID: 84961252646     PISSN: 07482337     EISSN: 14770393     Source Type: Journal    
DOI: 10.1177/0748233713498455     Document Type: Article

References (67)

1. Aebi HE, (1983) Catalase. In: Bergmeyer HU, Bergmeyer J, Grabi M, (eds) Methods of Enzymatic Analysis. 3rd ed., vol. III, Weinheim, Germany: Verlag Chemie, pp. 273-286.
2. Aggarwal BB, Harikumar KB, (2009). Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. International Journal of Biochemistry and Cell Biology 41 (1): 40-59.
3. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB, (2007) Bioavailability of curcumin: problems and promises. Molecular Pharmacology 4 (6): 807-818.
4. Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, et al. (2010) Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochemical Pharmacology 79 (3): 330-338.
5. Bashir S, Sharma Y, Irshad M, Gupta SD, Dogra TD, (2006) Arsenic-induced cell death in liver and brain of experimental rats. Basic Clinical Pharmacology and Toxicology 98 (1): 38-43.
6. Bhattacharyaa S, Haldar PK, (2012) Ameliorative effect Trichosanthes dioica root against arsenic-induced brain toxicity in albino rats. Toxicology and Environmental Chemistry 94 (4): 769-778.
7. Chavez EG, Jimenez I, Segura B, Del Razo LM, (2006) Lipid oxidative damage and distribution of inorganic arsenic and its metabolites in the rat nervous system after arsenite exposure: influence of alpha tocopherol supplementation. Neurotoxicology 27 (6): 1024-1031.
8. 2-induced renal epithelial (LLC-PK1) cell injury. Free Radical Biology and Medicine 24 (1): 49-54.
9. Damge C, Maincent P, Ubrich N, (2007) Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. Journal of Control Release 117 (2): 163-163.
10. Dinkova-Kostova AT, Talalay P, (1999) Relation of structure of curcumin analogs to their potencies as inducers of phase 2 detoxification enzymes. Carcinogenesis 20 (5): 911-914.
11. Dwivedi N, Flora SJ, (2011) Concomitant exposure to arsenic and organophosphates on tissue oxidative stress in rats. Food and Chemical Toxicology 49 (5): 1152-1159.
12. El-Demerdash FM, Yousef MI, Radwan FME, (2009) Ameliorating effect of curcumin on sodium arsenite-induced oxidative damage and lipid peroxidation in different rat organs. Food and Chemical Toxicology 47 (1): 249-254.
13. Feng SS, (2004) Nanoparticles of biodegradable polymers for new-concept chemotherapy. Expert Review of Medical Devices 1 (1): 115-125.
14. Flora SJS, (2002) Nutritional components modify metal absorption, toxic response and chelation therapy. Journal of Nutritional and Environmental Medicine 12: 53-67.
15. Flora SJ, Bhadauria S, Pant SC, Dhaked RK, (2005) Arsenic induced blood and brain oxidative stress and its response to some thiol chelators in rats. Life Sciences 77 (18): 2324-2337.
16. Ghosh A, Mandal AK, Sarkar S, Panda S, Das N, (2009) Nanoencapsulation of quercetin enhances its dietary efficacy in combating arsenic-induced oxidative damage in liver and brain of rats. Life Sciences 84 (3-4): 75-80.
17. Goldberg DM, Spooner RJ, (1983) Glutathione reductase. In: Bergmeyer HU, Bergmeyer J, Grabi M, (eds) Methods of Enzymatic Analysis Vol. III, 3rd ed. Weinheim, Germany.: Verlag Chemie, pp. 258-265.
18. Halliwell B, Gutteridge JMC, (2002) Free Radicals in Biology and Medicine, vol. 3. New York, NY: Oxford University Press Inc, pp. 105-245.
19. Itoh M, Takaoka M, Shibata A, Ohkita M, Matsumura Y, (2001) Preventive effect of lactacystin, a selective proteasome inhibitor, on ischemic acute renal failure in rats. Journal of Pharmacology and Experimental Therapeutics 298 (2): 501-507.
20. Itoh T, Zhang YF, Murai S, Saito H, Nagahama H, Miyate H, et al. (1990) The effect of arsenic trioxide on brain monoamine metabolism and locomotor activity of mice. Toxicology Letters 54 (2-3): 345-353.
21. Jadhav SH, Sarkar SN, Kataria M, Tripathi HC, (2007) Subchronic exposure to a mixture of groundwater-contaminating metals through drinking water induces oxidative stress in male rats. Environmental Toxicology and Pharmacology 23 (2): 205-211.
22. Kim HC, Jhoo WK, Suh JH, Shin EJ, Kato K, Hoko K, (2000) An immunocytochemical study of mitochondrial manganese-superoxide dismutase in the rat hippocampus after kainite administration. Neuroscience Letters 281 (1): 65-68.
23. Lankveld DP, Oomen AG, Krystek P, Neigh A, Troost-de Jong A, Noorlander CW, et al. (2010) The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 31 (32): 8350-8361.
24. Lao CD, Demierre MF, Sondak VK, (2006) Targeting events in melanoma carcinogenesis for the prevention of melanoma. Expert Review Anticancer Therapeutics 6 (11): 1559-1559.
25. Li H, Repa JJ, Valasek MA, Beltroy EP, Turley SD, German DC, et al. (2005) Molecular anatomical and biochemical events associated with neurodegeneration in mice into Nieman-Pick type C disease. Journal of Neuropathological Experimental Neurology 64 (4): 323-333.
26. Liang HF, Yang TF, Huang CT, Chen MC, Sung HW, (2005) Preparation of nanoparticles composed of poly(gamma-glutamic acid)-poly(lactide) block copolymers and evaluation of their uptake by HepG2 cells. Journal of Control Release 105 (3): 213-225.
27. Liu J, Liu Y, Goyer RA, Achanzar W, Waalkes MP, (2000) Metallothionein-i/ii null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals. Toxicological Science 55 (2): 460-467.
28. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ, (1951) Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 193 (1): 265-275.
29. Luna LG, (1968) Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology, 3rd ed. New York, USA: McGraw Hill. Book Company, pp. 168-169.
30. Lyn Patrick ND, (2003) Toxic metals and antioxidants: part II. The role of antioxidants in arsenic and cadmium toxicity. Alternative Medicine Review 8 (2): 106-128.
31. Madesh M, Balasubramanian KA, (1998) Microtiter plate assay for superoxide dismutase using MTT reduction by superoxide. Indian Journal of Biochemistry and Biophysics 35 (3): 184-188.
32. Majhi CR, Khan S, Leo MDM, Manimaran A, Sankar P, Sarkar SN, 2011 Effects of acetaminophen on reactive oxygen species and nitric oxide redox signaling in kidney of arsenic-exposed rats. Food and Chemical Toxicology 49 (4): 974-972.
33. Manimaran A, Sarkar SN, Sankar P, (2010) Toxicodynamics of subacute coexposure to groundwater contaminant arsenic and analgesic-antipyretic drug acetaminophen in rats. Ecotoxicology and Environmental Safety 73 (1): 94-100.
34. Meliker JR, Wahl RL, Cameron LL, Nriagu JO, (2007) Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environmental Health 6: 4.
35. Mishra D, Flora SJ, (2008) Differential oxidative stress and DNA damage in rat brain regions and blood following chronic arsenic exposure. Toxicology and Industrial Health 24 (4): 247-256.
36. Mohanty C, Sahoo SK, (2010) The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials 31 (25): 6597-6611.
37. Mukerjee A, Vishwanatha JK, (2009) Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Research 29 (10): 3867-3875.
38. Nordberg J, Arner ES, (2001) Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radical Biology and Medicine 31 (11): 1287-1312.
39. NRC (1999) Arsenic in the Drinking Water. Washington, DC: National Research Council, National Academy Press.
40. Paglia DE, Valentine W, (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. Journal of Laboratory Clinical Medicine 70 (1): 158-169.
41. Pari L, Amali DR, (2005) Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine-induced hepatotoxicity in rats. Journal of Pharmacy and Pharmaceutical Sciences 8 (1): 115-123.
42. Patel HV, Kalia K, (2010) Sub-chronic arsenic exposure aggravates nephrotoxicity in experimental diabetic rats. Indian Journal of Experimental Biology 48 (7): 762-768.
43. Paula FB, Gouvea CM, Alfredo PP, Salgado I, (2005) Protective action of a hexane crude extract of Pterodon emarginatus fruits against oxidative and nitrosative stress induced by acute exercise in rats. BMC Compliment Alternative Medicine 5: 17-25.
44. Piao F, Ma N, Hiraku Y, Murata M, Oikawa S, Cheng F, et al. (2005) Oxidative DNA damage in relation to neurotoxicity in the brain of mice exposed to arsenic at environmentally relevant levels. Journal of Occupational Health 47 (5): 445-449.
45. Prozialeck WC, Edwards JR, Nebert DW, Woods JM, Barchowsky A, Atchison WD, (2007) Vascular system as a target of metal toxicity. Toxicological Sciences 102 (2): 207-218.
46. Ramos O, Carrizales L, Yanez L, Mejia J, Batres L, Ortiz D, et al. (1995) Arsenic increased lipid peroxidation in rat tissues by a mechanism independent of glutathione levels. Environmental Health Perspectives 103 (1): 85-88.
47. Sankar P, Telang AG, Manimaran A, (2012) Protective effect of curcumin on cypermethrin-induced oxidative stress in Wistar rats. Experimental and Toxicological Pathology 64 (5): 487-493.
48. Santra A, Das Gupta J, De BK, Roy B, Guha Mazumer DN, (1999) Hepatic manifestations in chronic arsenic toxicity. Indian Journal of Gastroenterology 18 (4): 152-155.
49. Sedlak J, Lindsay RH, (1968) Estimation of total, protein-bound and nonprotein bound sulfhydryl groups in tissue with Ellman's reagent. Analytical Biochemistry 25 (1): 192-205.
50. Shaikh J, Ankolab DD, Beniwal V, Singha D, Ravi Kumar MNV, (2009) Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. European Journal of Pharmaceutical Sciences 37 (3-4): 223-230.
51. Shehzad A, Wahid F, Lee YS, (2010) Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Archiv der Pharmazie. (Weinheim) 343 (9): 489-499.
52. Shukla PK, Khanna VK, Khan MY, Srimal RC, (2003) Protective effects of curcumin against lead neurotoxicity in rat. Human and Experimental Toxicology 22 (12): 653-658.
53. Sinha M, Manna P, Sil PC, (2008) Protective effect of arjunolic acid against arsenic induced oxidative stress in mouse brain. Journal of Biochemistry and Molecular Toxicology 22 (1): 15-26.
54. Thiyagarajan M, Sharma SS, (2004) Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sciences 74 (8): 969-985.
55. Tirkey N, Kaur G, Vij G, Chopra K, (2005) Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys. BMC Pharmacology 5: 15.
56. Tiwari H, Rao MV, (2010) Curcumin supplementation protects from genotoxic effects of arsenic and fluoride. Food and Chemical Toxicology 48 (5): 1234-1238.
57. Tripathi N, Kannan GM, Pant BP, Jaiswal DK, Malhotra PR, Flora JS, (1997) Arsenic-induced changes in certain neurotransmitter levels and their recoveries following chelation in rat whole brain. Toxicology Letters 92 (3): 201-208.
58. Tsai YM, Chien CF, Lin LC, Tsai TH, (2011) Curcumin and its nano-formulation: the kinetics of tissue distribution and blood-brain barrier penetration. International Journal of Pharmacology 416 (1): 331-338.
59. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M, (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico Biological Interactions 160 (1): 1-40.
60. Vizcaya-Ruiz AD, Barbier O, Ruiz-Ramos R, Cebrian ME, (2009) Biomarkers of oxidative stress and damage in human populations exposed to arsenic. Mutation Research 674 (1-2): 85-92.
61. Xie X, Tao Q, Zou Y, Zhang F, Guo M, Wang Y, et al. (2011) PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. Journal of Agricultural and Food Chemistry 59 (17): 9280-9289.
62. Yadav A, Lomash V, Samim M, Flora SJ, (2012) Curcumin encapsulated in chitosan nanoparticles: a novel strategy for the treatment of arsenic toxicity. Chemico Biological Interactions 199 (1): 49-61.
63. Yadav AK, Mishra P, Mishra AK, Jain S, Agrawal GP, (2007) Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Nanomedicine 3 (4): 246-257.
64. Yadav RS, Sankhwar ML, Shukla RK, Chandra R, Pant AB, Islam F, et al. (2009) Attenuation of arsenic neurotoxicity by curcumin in rats. Toxicology and Applied Pharmacology 240 (3): 367-376.
65. Yadav RS, Shukla RK, Sankhwar ML, Patel DK, Ansari RW, Pant AB, et al. (2010) Neuroprotective effect of curcumin in arsenic-induced neurotoxicity in rats. Neurotoxicology 31 (5): 533-539.
66. Yang KY, Lin LC, Tseng TY, Wang SC, Tsai TH, (2007) Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. Journal of Chromatography B 853 (1-2): 183-189.
67. Yousef MI, El-Demerdash FM, Radwan FM, (2008) Sodium arsenite induced biochemical perturbations in rats: ameliorating effect of curcumin. Food and Chemical Toxicology 46 (11): 3506-3511.